NCT03445715View on ClinicalTrials.gov

ART-I02 in Patients With Rheumatoid Arthritis With Inflamed Wrists

PHASE1UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

January 31, 2020

Conditions
Rheumatoid Arthritis
Interventions
GENETIC

ART-I02

Single Intra-articular injection in the wrist joint

Trial Locations (1)

AB T2N 4N1

University of Calgary, Division of Rheumatology, Cumming School of Medicine, Calgary

Sponsors

Lead Sponsor

Arthrogen
All Listed Sponsors
lead

Arthrogen

INDUSTRY

NCT03445715 - ART-I02 in Patients With Rheumatoid Arthritis With Inflamed Wrists | Biotech Hunter | Biotech Hunter